1.
Allard P, Alhaj N, Lobitz S, Cario H, Jarisch A, Grosse R, Oevermann L, Hakimeh D, Tagliaferri L, Kohne E, Kopp-Schneider A, Kulozik AE, Kunz JB. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea. haematol [Internet]. 2021Oct.28 [cited 2022Jun.27];. Available from: https://haematologica.org/article/view/haematol.2021.278952